Light Sciences Oncology

About:

Light Sciences Oncology develops light-activated drug products to treat patients with solid tumor cancers.

Top Investors: Adams Street Partners, Novo Holdings, Fidelity Ventures, Essex Woodlands Healthcare Partners, Johnson & Johnson Development Corporation

Description:

Light Sciences Oncology develops cancer and tumor treatment drugs. Additionally, it offers oncology drugs research and development services to treat hepatocellular carcinoma, metastatic colorectal cancer, and glioma. Light Sciences Oncology was founded in 1994 and is headquartered in Bellevue, Washington.

Total Funding Amount:

$182M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bellevue, Washington, United States

Founded Date:

1994-01-01

Contact Email:

info(AT)lsoncology.com

Founders:

Craig Watjen, Llew Keltner

Number of Employees:

11-50

Last Funding Date:

2019-01-03

IPO Status:

Private

Industries: